Testing effectiveness (Phase 2)Looking for participantsNCT06052436
What this trial is testing
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
Who this might be right for
Systemic Inflammatory Response Syndrome
Hospital General Universitario Gregorio Marañon 24